Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function
Clinical trial NCT02509624 · COMPLETED
Trial details
- NCT number
- NCT02509624
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-18
- Primary completion
- 2015-12-15
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.